The emerging landscape of reimbursement of regenerative medicine products in the UK: publications, policies and politics

Abstract : Structured Abstract Aims This paper aims to map the trends and analyse key institutional dynamics that are constituting the policies for reimbursement of Regenerative Medicine (RM), especially in the UK. Materials & Methods Two quantitative publications studies using Google Scholar and a qualitative study based on a larger study of 43 semi-structured interviews. Results Reimbursement has been a growing topic of publications specific to RM and independent from orphan drugs. Risk-sharing schemes receive attention amongst others for dealing with RM reimbursement. Trade organisations have been especially involved on RM reimbursement issues and have proposed solutions. Conclusion The policy and institutional landscape of reimbursement studies in RM is a highly variegated and conflictual one and in its infancy.
Document type :
Journal articles
Complete list of metadatas

Cited literature [25 references]  Display  Hide  Download

https://halshs.archives-ouvertes.fr/halshs-01609518
Contributor : Aurélie Mahalatchimy <>
Submitted on : Tuesday, April 3, 2018 - 10:25:32 AM
Last modification on : Friday, December 7, 2018 - 2:30:03 PM

File

RM article politics reimbursem...
Files produced by the author(s)

Identifiers

Collections

Citation

Aurélie Mahalatchimy, Alex Faulkner. The emerging landscape of reimbursement of regenerative medicine products in the UK: publications, policies and politics. Regenerative Medicine, Future Medicine, 2017, pp.611 - 622. ⟨10.2217/rme-2017-0041⟩. ⟨halshs-01609518⟩

Share

Metrics

Record views

165

Files downloads

216